Rf Acquisition Corp Ii Unit

AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing

RF Acquisition Corp. Announces Updated Per Share Redemption Price in Connection With Upcoming Special Meeting

RF Acquisition Corp II Announces the Separate Trading of its Ordinary Shares and Rights Commencing July 5, 2024